Sucampo Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$409.3M

662 transactions

Summary

Sucampo Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $803KSales: $176.3M40 insiders

Date	Insider	Type	Value
2018-02-13	Ueno Ryuji	U	$97.3M
2018-02-13	Kuno Sachiko	U	$92.5M
2018-02-13	Kiener Peter A(Chief Science Officer)	D	$2.4M
2018-02-13	Meyenburg Jason Patrick(Chief Commercial Officer)	D	$1.1M
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$1.1M
2018-02-13	Bryan Jones W.(Sr. Vice Pres., BD & Licensing)	D	$1.1M
2018-02-13	PFREUNDSCHUH PETER P.(CFO)	D	$1.1M
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$847K
2018-02-13	Meyenburg Jason Patrick(Chief Commercial Officer)	D	$544K
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$432K
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$281K
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$277K
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$185K
2018-02-13	Lichtlen Peter(Chief Medical Officer)	D	$140K
2018-02-13	Driggs Alex(General Counsel & Corp. Sec.)	D	$110K
2018-02-13	Driggs Alex(General Counsel & Corp. Sec.)	D	$101K
2018-02-13	Bryan Jones W.(Sr. Vice Pres., BD & Licensing)	D	$93K
2018-02-13	Driggs Alex(General Counsel & Corp. Sec.)	D	$68K
2018-02-13	Driggs Alex(General Counsel & Corp. Sec.)	D	$50K
2018-02-13	PFREUNDSCHUH PETER P.(CFO)	D	$5K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Sucampo Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope